Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. International Journal of Environmental Sciences, [S. l.], v. 11, n. 12s, p. 1360–1367, 2025. DOI: 10.64252/8crhea08. Disponível em: https://theaspd.com/index.php/ijes/article/view/2559.. Acesso em: 5 aug. 2026.